- Home
- DCGO vs SRZN Comparison
DCGO vs SRZN Comparison
Compare DCGO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- SRZN
- Stock Information
- Founded
- DCGO 2015
- SRZN 2015
- Country
- DCGO United States
- SRZN United States
- Employees
- DCGO N/A
- SRZN N/A
- Industry
- DCGO Managed Health Care
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- DCGO Health Care
- SRZN Health Care
- Exchange
- DCGO Nasdaq
- SRZN Nasdaq
- Market Cap
- DCGO 136.0M
- SRZN 120.0M
- IPO Year
- DCGO N/A
- SRZN N/A
- Fundamental
- Price
- DCGO $1.09
- SRZN $11.95
- Analyst Decision
- DCGO Strong Buy
- SRZN Strong Buy
- Analyst Count
- DCGO 3
- SRZN 2
- Target Price
- DCGO $3.37
- SRZN $38.50
- AVG Volume (30 Days)
- DCGO 4.3M
- SRZN 39.1K
- Earning Date
- DCGO 11-10-2025
- SRZN 11-07-2025
- Dividend Yield
- DCGO N/A
- SRZN N/A
- EPS Growth
- DCGO N/A
- SRZN N/A
- EPS
- DCGO N/A
- SRZN N/A
- Revenue
- DCGO $368,093,385.00
- SRZN $3,604,000.00
- Revenue This Year
- DCGO N/A
- SRZN N/A
- Revenue Next Year
- DCGO N/A
- SRZN N/A
- P/E Ratio
- DCGO N/A
- SRZN N/A
- Revenue Growth
- DCGO N/A
- SRZN N/A
- 52 Week Low
- DCGO $0.97
- SRZN $5.90
- 52 Week High
- DCGO $5.68
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- DCGO 41.58
- SRZN 51.23
- Support Level
- DCGO $0.97
- SRZN $11.51
- Resistance Level
- DCGO $1.17
- SRZN $14.38
- Average True Range (ATR)
- DCGO 0.08
- SRZN 0.67
- MACD
- DCGO 0.01
- SRZN -0.17
- Stochastic Oscillator
- DCGO 34.43
- SRZN 55.52
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).